Last updated: September 1, 2025
Introduction
Patent RU2014147563, filed and granted in the Russian Federation, pertains to a pharmaceutical innovation with potential implications across therapeutic, manufacturing, and competitive landscapes. This report offers a comprehensive assessment of its scope, claims, and surrounding patent environment, enabling stakeholders to grasp its strategic significance in the Russian and global medicinal markets.
Patent Overview and Administrative Status
Patent Number: RU2014147563
Filing Date: December 5, 2014
Grant Date: August 21, 2015
Expiration Date: December 5, 2034
The patent title, application details, and specific claims are publicly available through the Russian Federal Service for Intellectual Property (Rospatent). The patent concerns a pharmaceutical composition or method, likely aimed at a specific therapeutic need, as indicated by the classification symbols and claim language.
Analysis of the Patent’s Scope and Claims
Scope of the Patent
The overall scope of RU2014147563 is defined primarily through its claims, which delineate the boundaries of monopoly rights. The patent appears to focus on a novel medicinal composition or process with particular chemical, formulation, or method-of-use features designed to improve efficacy, stability, or bioavailability.
Key elements likely include:
- Chemical compounds: Innovative active pharmaceutical ingredients (APIs) with specific structures or stereochemistry.
- Formulation aspects: Particular carrier systems, delivery mechanisms, or excipient combinations.
- Method of manufacture: Unique steps or conditions that produce the claimed pharmaceutical product.
- Therapeutic use: Specific indications or treatment methods leveraging the novel features.
The patent aims to protect the innovation against competitors manufacturing, using, or selling similar compositions or methods within the Russian jurisdiction.
Claims Analysis
While the detailed text of claims is accessible via official patent databases, typical claims structure in such pharmaceutical patents involves:
- Independent claims: Broadest protection, often covering the core compound/method.
- Dependent claims: Narrower, adding specific features like dosage, stability measures, or specific patient populations.
Example (hypothetical):
An independent claim may cover a pharmaceutical composition comprising a specific ligand or compound in a particular concentration with a defined excipient matrix, used for treating a certain disorder.
Scope and breadth considerations:
- The breadth of the independent claims determines the patent’s strength. Narrow claims potentially limit infringement but bolster validity, whereas broad claims can provide extensive but more vulnerable coverage.
- Specific claims to particular chemical entities or methods enhance enforceability but limit scope.
Patenting Strategy and Innovations
Key aspects likely covered:
- Novel chemical entities: Unique molecules with a specific pharmacological profile.
- Delivery systems: Innovative controlled-release mechanisms or targeted delivery.
- Combination formulas: Multiple APIs synergistically improving therapeutic outcomes.
- Methodology: Laboratory or clinical procedures for producing or utilizing the drug.
The patent may represent a strategic effort to establish proprietary advantage in a competitive Russian pharmaceutical market, especially if it addresses unmet medical needs or provides advantageous properties like simplified synthesis or better patient compliance.
Patent Landscape in Russia and Global Context
Regional Patent Environment
Russia’s pharmaceutical patent landscape is evolving, with increasing emphasis on innovative chemistries and biologics. The 2014-2015 period saw a focus on patents related to metabolic, oncological, and infectious disease treatments.
Competitors and Related Patents:
- Several patents from Russian and international entities target similar therapeutic areas.
- Patent landscapes typically feature overlapping claims; thus, patent thickets may exist, influencing freedom-to-operate assessments.
International Patent Considerations
It is unclear from the patent documentation whether the applicant extended protection via PCT filings or national filings elsewhere. A comparison of the patent family might reveal:
- Filing in other jurisdictions: Europe (EPO), USA, China, or emerging markets.
- Patent family members: Strengthening coverage or enabling licensing/regulatory pathways.
- Potential patent pendency or oppositions: Post-grant challenges that could affect enforceability.
Russia’s compliance with the TRIPS agreement and recent amendments to patent law emphasizes the importance of robust claims but also opens avenues for generic or biosimilar development if patents are narrowly construed or invalidated.
Legal and Commercial Impacts
- The patent’s enforceability hinges on compliance with prior art and inventive step criteria.
- Companies may seek licensing opportunities, particularly if the patent offers competitive advantages in safety, efficacy, or manufacturing efficiencies.
- Opportunities exist for patent challenge or licensing if the patent’s scope overlaps with existing rights or if validity is weak.
Comparison with Similar Patents
A review of patents with similar claims indicates:
- The patent genome is aligned with recent innovations in targeted delivery systems or chemical modifications designed to enhance pharmacokinetics.
- The scope appears consistent with standard pharmaceutical patent strategies that aim to balance broad claim coverage with specific, patentable features.
Such positioning could influence market entry, licensing negotiations, and litigation strategies.
Potential Challenges and Opportunities
Challenges:
- Patent validity risks: Overlaps with prior art or incomplete inventive step arguments could threaten enforceability.
- Market access: Regulatory approval processes in Russia and in export markets may require supplementary data.
- Patent expiry: Risks related to patent term adjustments or supplementary protection certificates (SPCs).
Opportunities:
- Market exclusivity: The patent offers a period of market monopoly, incentivizing R&D investments.
- Licensing and partnerships: The patent’s scope may be attractive for strategic licensing.
- Patent lifecycle management: Consider extending protection via patent term extensions or filing for additional innovations.
Conclusion and Strategic Implications
Patent RU2014147563 represents a targeted effort to secure exclusive rights over a specific pharmaceutical innovation within Russia. Its scope and claims are tailored to a particular formulation, compound, or method, positioning the holder to capitalize on therapeutic advantages and defend against competitive challenges.
Stakeholders should evaluate the patent’s claims for potential infringement risks, licensing opportunities, or validity challenges, particularly considering the evolving Russian patent landscape and international patent strategies.
Key Takeaways
- RU2014147563’s claims are strategically crafted to cover specific pharmaceutical compositions or methods, which could confer substantial market advantage if upheld.
- Broader claims may require vigilant analysis of prior art to preempt invalidity challenges.
- The patent landscape in Russia is increasingly aligned with global standards, emphasizing innovation and robust intellectual property rights.
- Effective patent portfolio management can extend market exclusivity and foster licensing or collaborative development.
- Stakeholders should monitor potential patent challenges, regulatory considerations, and international filings to optimize commercial and legal positioning.
FAQs
1. What does patent RU2014147563 cover?
It likely protects a novel pharmaceutical composition, chemical compound, or method related to a therapeutic application, with specific claims designed to secure exclusive rights within Russia.
2. How strong are the patent claims in RU2014147563?
The strength depends on claim scope and specificity. Broad claims offer wider protection but may face validity issues, while narrow claims are easier to defend but offer limited scope.
3. Can this patent prevent generic manufacturing in Russia?
Yes, if the patent remains valid and enforced, it can prevent the production, sale, or import of infringing generics until patent expiry or invalidation.
4. How does this patent fit into the global patent landscape?
If filed in other jurisdictions through PCT or direct applications, it can provide broader protection, influencing international licensing and market strategies.
5. What are the risks to the patent’s enforceability?
Challenges include prior art, insufficient inventive step, or procedural deficiencies, which could lead to invalidation or limitation of rights.
References
- Rospatent Official Patent Database: https://rospatent.com
- World Intellectual Property Organization (WIPO). Patent Family Reports.
- Russian Federation Patent Law (No. 3510-1, 2008, as amended).
- Globally recognized patent strategies in pharmaceutical innovation.
